Search for: "Amgen Inc" Results 81 - 100 of 696
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jun 2007, 11:46 am
By Sherri Oslick -- On Monday, Amgen Inc. of Thousand Oaks, CA announced that it would acquire drug company Ilypsa, Inc. of Santa Clara, CA for $420 million cash. [read post]
4 May 2009, 8:10 pm
By Andrew Williams -- Last year, a panel of the Federal Circuit affirmed the International Trade Commission's (ITC's) grant of summary judgment against Amgen in its attempts to block importation of Roche's Micera ® peglylated erythropoietin product. [read post]
24 Nov 2009, 1:10 pm
The Indiana Attorney General's Office joined in a lawsuit along with 13 other states against Amgen Inc., alleging the pharmaceutical manufacturer illegally promoted its anemia-treatment drug Aranesp by offering physicians kickbacks and other illegal inducements to prescribe it. [read post]
19 Dec 2012, 9:47 pm by Ben Vernia
District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. [read post]
31 May 2023, 9:43 am by Rose Hughes
Cir. 2021), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement (Amgen Inc v Sanofi, No. 21-757). [read post]
20 Jan 2011, 1:32 pm by California Stem Cell Report
The California stem cell agency today named Ellen Feigal, an executive at Amgen, Inc., to the new position of vice president for research and development. [read post]
7 Jun 2007, 7:39 pm
By Sherri Oslick -- On Wednesday, Amgen Inc. of Thousand Oaks, CA announced that it would acquire drug company Alantos Pharmaceuticals of Cambridge, MA for $300 million cash. [read post]
23 Jul 2015, 9:59 pm by Patent Docs
By Andrew Williams -- As we have been reporting this week, the Federal Circuit handed down its decision in Amgen Inc. v. [read post]
22 Apr 2013, 5:19 pm by Cynthia Marcotte Stamer
California-based biotechnology giant Amgen, Inc. has agreed to pay $24,9 Million to resolve Justice Department False Claims Act charges that the biotechnology giant violated the False Claims Act by paying illegal kickbacks to long-term care pharmacy providers to promote the sale of its Aranesp and other products. [read post]
18 Jan 2024, 5:14 pm by bklemm@foley.com
Share on LinkedInShare on TwitterShare by EmailShare Back to top The USPTO has issued “Guidelines for Assessing Enablement in Utility Applications and Patents in View of the Supreme Court Decision in Amgen Inc. et al. v. [read post]